• SENSEX 72,529.07
    -242.65 (--0.33%)
  • BANKNIFTY 54,259.95
    -211.70 (--0.39%)
  • Cube Highways
    156.41 162.00(%)
  • NSE
    1,793.70 1,878.00(%)
  • 360 ONE
    1,019.75 906.20(%)
  • SS Retail
    775.00 888.00(%)
  • Cupid
    292.35 298.95(%)
  • R Systems Intl.
    305.25 446.55(%)
  • GE Vernova T&D
    4,225.00 5,650.00(%)
  • Lords Mark Industries
    84.89 60.00(%)
  • PB Fintech.
    1,076.35 1,076.35(%)
  • Azad Engineering
    2,997.65 2,997.65(%)
  • Hero Motors
    140.75 156.03(%)
  • HDFC Bank
    720.00 1,020.35(%)
  • Reliance Industries
    1,182.05 1,182.05(%)
  • Delhivery
    418.15 524.25(%)
  • Ather Energy
    1,404.00 542.20(%)
  • Varmora Granito
    163.45 163.45(%)
  • Bharti Airtel
    1,788.00 2,174.70(%)
  • Indian Hotels Co
    725.50 757.10(%)
  • ICICI Lombard
    1,498.00 1,423.95(%)
  • Bajaj Finance
    961.65 788.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Everest Organics Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4614.0
  • ISIN : INE334C01029
222.70 7 (3.27%)
  • As on 29 Sep 2026 (EOD)

  • Today’s Low

    213.45

  • Today’s High

    230.05

  • Open

    215.20

  • Perv Close

    215.65

  • 52W Low

    197.00

  • 52W High

    536.40

Key Indicators

  • P/E(TTM)

    42.26

  • Mar.Cap (₹Cr.)

    222.11

  • Div & Yield %

    0.00

  • Book Value(₹)

    79.69

  • Debt-Equity Ratio

    3.27

  • AGM Date

    29-Sep-2026

  • EPS

    5.27

  • P/E Ratio

    42.26

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    222.11

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    9.97

  • BV (₹)

    79.70

  • Sales( ₹ in Cr.)

    196.16

  • NP (in Cr.)

    5.55

  • NP Var(%)

    530.0

  • Div%

    0.0

  • CPS (₹)

    12.10

  • EPS (₹)

    5.60

  • Traded Value (₹ in Lakhs)

    222.11

  • 52 Week High

    536.40

  • 52 Week Low

    197.00

  • Price BSE

    223.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    222.11

  • P/C Ratio

    18.50

  • P/E Ratio

    40.10

  • Price Vs.BV

    5.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 225.44 182.37 226.49 208.73 230.22 207.36
Excise Duty 29.28 22.89 29.25 25.69 30.17 25.79
Net Sales 196.16 159.48 197.24 183.04 200.05 181.57
Other Income 1.25 0.68 0.89 6.94 2.21 1.06
Stock Adjustments 1.95 -1.04 -0.56 3.23 4.51 8.22
Total Income 199.36 159.12 197.57 193.21 206.77 190.85
EXPENDITURE :            
Raw Materials 126.27 98.53 124.64 126.31 141.72 117.13
Power and Fuel Cost 12.90 14.83 15.40 18.88 14.70 12.36
Employee Cost 15.48 16.35 18.80 16.30 16.33 15.26
Other Manufacturing Expenses 11.54 10.85 15.37 13.66 15.80 13.91
Selling and Administration Expenses 9.27 9.11 10.52 9.75 8.66 7.65
Miscellaneous Expenses 2.84 1.52 0.96 0.44 0.92 0.64
Employee Benefit Expenses 15.48 16.35 18.80 16.30 16.33 15.26
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 178.30 151.20 185.69 185.35 198.13 166.94
Operating Profit 21.06 7.91 11.88 7.87 8.64 23.91
Interest 6.53 5.19 5.47 3.31 3.10 3.26
Gross Profit 14.53 2.72 6.41 4.56 5.54 20.65
Depreciation 6.48 5.96 5.80 4.47 3.80 3.37
Profit Before Tax 8.05 -3.24 0.61 0.09 1.74 17.28
Current Tax 2.26 0.00 0.10 0.02 0.29 3.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.24 -1.95 0.37 0.26 0.31 0.54
Reported Net Profit 5.55 -1.29 0.14 -0.18 1.14 13.72
Extraordinary Items 0.00 0.00 0.00 -0.10 0.00 0.00
Adjusted Net Profit 5.55 -1.29 0.14 -0.08 1.14 13.72
Adjustment below Net Profit 0.00 -1.60 0.00 0.00 -0.12 -0.14
P & L Balance brought forward 31.22 34.11 34.49 38.80 38.58 22.47
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.51 0.40 0.80 1.20
P & L Balance carried down 36.76 31.22 34.11 38.21 38.80 34.85
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 15.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 1.50
Earnings Per Share-Unit Curr 5.71 -1.33 0.17 -0.23 1.43 17.14
Earnings Per Share(Adj)-Unit Curr 5.71 -1.33 0.17 -0.23 1.43 17.14
Book Value 77.73 71.00 57.30 57.77 58.50 58.22
Book Value(Adj)-Unit Curr 77.73 71.00 57.30 57.77 58.50 58.22

Shareholding Pattern

  • Promoter Group

    59.60%

  • Public Share Holding

    40.40%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 169,128 169,128.00 169,128 169,128
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 169,128 1.74 169,128 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,949,262 40.67 3,949,262 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,669,371 17.19 1,669,371 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,618,633 57.86 5,618,633 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,214 0.02 2,214 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 36 0.00 36 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,250 0.02 2,250 3
2] Non Institution
Bodies Corporate 821,118 8.46 813,702 51
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 201,844 2.08 141,004 142
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 87,068 0.90 87,068 77
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,442,589 14.86 1,442,589 14
Individuals holding nominal share capital up to Rs. 1 lakh 1,174,338 12.09 930,726 7,526
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,920,515 40.37 3,608,647 7,814
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,710,526 100.00 9,398,658 7,827

Company Background

Everest Organics LtdPharmaceuticals - Indian - Bulk Drugs

  • Everest Organics Ltd
  • BSE Code : 4614.0
  • ISIN : INE334C01029

  • Incorporation Year

    1993

  • Registered Office

    Aroor Village
    Sadasivpet Mandal, Medak,
    Telangana-502291

  • Telephone

    91-8455-250113

  • FAX

    91-8455-250114

  • Chairman

    SUNDARA PRASAD VENKATA SATYA SRIKAKOLAPU

  • Managing Director

  • Company Secretary

  • Auditor

    P S N Ravishanker & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Everest Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 27,266.65 7,217.19 6,929.05 35.88 43.78
Astrazeneca Phar 6,254.35 2,304.07 2,275.58 92.18 27.86
Glaxosmi. Pharma 2,787.25 3,932.76 3,790.20 44.52 58.17
Novartis India 1,933.35 393.10 354.33 48.82 15.94
Cipla 1,383.00 20,102.60 18,979.95 36.35 13.88
Bliss GVS Pharma 710.05 773.53 729.81 65.99 12.51
Fermenta Biotec. 549.30 474.15 450.25 25.64 18.77
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Guj. Themis Bio. 404.40 168.25 165.82 108.13 18.05
Ambalal Sarabhai 39.24 19.52 3.94 72.67 6.77